Our data suggest that unlike for KRAS-mutated cancer cells, where FMD reverts the vitamin C-mediated HO-1 upregulation, KRAS-wild-type tumors are more resistant to oxidative insults, possibly because of their ability to rapidly neutralise radical species4,11,12,27. The gene discussed is KRAS; the disease is cancer.